Literature DB >> 18234160

Nestin small interfering RNA (siRNA) reduces cell growth in cultured astrocytoma cells.

Li-Chun Wei1, Mei Shi, Rong Cao, Liang-Wei Chen, Ying-Shing Chan.   

Abstract

Nestin is an embryonic intermediate filament that transiently expressed in the neural stem/progenitor cells in the developing central nervous system (CNS). Growing evidence has shown that abundant expression of nestin also occurs in both pathological glial-derived tumor cells and reactive astrocytes in various CNS injuries, implying that nestin may play a crucial role in cell growth or proliferation of astrocyte-derived tumor cells. In the present study, we have investigated the possible role of nestin expression in cell growth or survival of CNS tumor cells by using novel small interfering RNA (siRNA) method in cell culture of rat astrocytoma C6 cell line. The nestin expression and cell growth of the cultured astrocytoma cells were examined after nestin siRNA duplex was delivered by cell transfection for 6 h and cell culture was maintained for 48 h. It revealed an effective suppression influence of nestin siRNA on cell growth of cultured astrocytoma cells in a dose-dependent manner. Quantitative data analysis showed that the doses of nestin siRNA at 30-120 nM significantly decreased both cell numbers and expression levels of nestin mRNA and protein. The nestin siRNA also suppressed expression of cellular glial fibrillary acid protein but showed no obvious influence on expression level of Ki-67 protein (a cell proliferation marker). This study has provided in vitro evidence that nestin siRNA can effectively block nestin expression and reduce cell growth of the cultured C6 astrocytoma cells, strongly suggesting that nestin siRNA-induced suppression of tumor cell growth may provide a potential novel clinical therapy against CNS astroglioma events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18234160     DOI: 10.1016/j.brainres.2007.11.026

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Nestin-expressing vascular wall cells drive development of pulmonary hypertension.

Authors:  Farhan Saboor; Ansgar N Reckmann; Claudia U M Tomczyk; Dorothea M Peters; Norbert Weissmann; Andre Kaschtanow; Ralph T Schermuly; Tatyana V Michurina; Grigori Enikolopov; Dieter Müller; Andrea Mietens; Ralf Middendorff
Journal:  Eur Respir J       Date:  2015-12-23       Impact factor: 16.671

2.  Clinical value of CD133 and nestin in patients with glioma: a population-based study.

Authors:  Rikke H Dahlrot; Steinbjørn Hansen; Stine S Jensen; Henrik D Schrøder; Jacob Hjelmborg; Bjarne W Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 3.  What is the clinical value of cancer stem cell markers in gliomas?

Authors:  Rikke Hedegaard Dahlrot; Simon Kjær Hermansen; Steinbjørn Hansen; Bjarne Winther Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

4.  Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors.

Authors:  Masayuki Kanamori; Toshihiro Kumabe; Yukihiko Sonoda; Yoshikazu Nishino; Mika Watanabe; Teiji Tominaga
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

5.  Knockdown of Nestin inhibits proliferation and migration of colorectal cancer cells.

Authors:  Jing Li; Rui Wang; Lei Yang; Qi Wu; Qinwan Wang; Zhengchao Nie; Yongchun Yu; Ji Ma; Qiuhui Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  MiR-125b orchestrates cell proliferation, differentiation and migration in neural stem/progenitor cells by targeting Nestin.

Authors:  Yi Cui; Zhifeng Xiao; Jin Han; Jie Sun; Wenyong Ding; Yannan Zhao; Bing Chen; Xiaoran Li; Jianwu Dai
Journal:  BMC Neurosci       Date:  2012-09-28       Impact factor: 3.288

7.  Suppression of Nestin reveals a critical role for p38-EGFR pathway in neural progenitor cell proliferation.

Authors:  Wentao Hu; Hong Lu; Shang Wang; Wenhan Yin; Xujie Liu; Lin Dong; Richard Chiu; Li Shen; Wen-Jing Lu; Feng Lan
Journal:  Oncotarget       Date:  2016-12-27

8.  High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas.

Authors:  Tianshen Hu; Vamsidhara Vemireddy; Kimmo J Hatanpaa; Chan Foong; Jack M Raisanen; Dwight Oliver; Matthew C Hiemenz; Dennis K Burns; Charles L White; L Anthony Whitworth; Bruce Mickey; Martha Stegner; Amyn A Habib; Karen Fink; Elizabeth A Maher; Robert M Bachoo
Journal:  J Neurooncol       Date:  2014-02-12       Impact factor: 4.506

9.  Role of the stem cell-associated intermediate filament nestin in malignant proliferation of non-small cell lung cancer.

Authors:  Zhenguang Chen; Jiancheng Wang; Lie Cai; Beilong Zhong; Honghe Luo; Yuantao Hao; Weihua Yu; Binchao Wang; Chunhua Su; Yiyan Lei; Amos Ela Bella; Andy Peng Xiang; Tao Wang
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  Contribution of nestin positive esophageal squamous cancer cells on malignant proliferation, apoptosis, and poor prognosis.

Authors:  Beilong Zhong; Tao Wang; Zhenguang Chen; Xueping Lun; Jinli Zhang; Sannv Zheng; Weilin Yang; Weiqiang Li; Andy Peng Xiang
Journal:  Cancer Cell Int       Date:  2014-06-20       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.